References
Bešbaš N, Damargue, I, Ozen S et al. (1994) Association of antiphospholipid antibodies with systemic lupus erythematosus in a child presenting with chorea: a case report. Eur J Pediatr 153: 891–893
Özsoylu S, Strauss HS, Diamond LK (1962) Effect of corticosteroids on coagulation of the blood. Nature (London) 195:1214–1215
Özsoylu S, Tugcu K, Coteli I et al (1980) Effect of intravenous adrenalin infussion and corticosteroid treatments in patients with von Willebrand's disease. Acta Haematol 64:289–293
Özturk G, Özsoylu S, Gursel T (1994) Effect of methylprednisolone on F VIII: C and vWF levels. Eur J Haematol 53: 119–120
Özsoylu S, Erturk G (1991) Oral megadose methylprednisolone for childhood acute idiopathic thrombocytopenic purpura. Blood 77:1856–1857
References
Asherson RA, Baguley E, Pal C, Hughes GR (1991) Antiphospholipid syndrome: five year follow-up. Ann Rheum Dis 50:805–810
Cameron JS (1984) Coagulation and thromboembolic complications in the nephrotic syndrome. Adv Nephrol 13: 75–114
Hahn BH (1993) Management of systemic lupus erythematosus. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatoloty. WB Saunders Co, Philadelphia, pp 1043–1056
Hayball PJ, Cosh DG, Ahern MJ et al. (1992) High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmocokinetics and clinical response. Eur J Clin Pharmacol 42: 85–88
Özsoylu S, Strauss HS, Diamond LK (1962) Effect of corticosteroids on coagulation of the blood. Nature 195: 1214–1215
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Özsoylu, S., Bešbaš, N., Ozen, S. et al. Corticosteroid and hypercoagulability. Eur J Pediatr 154, 687 (1995). https://doi.org/10.1007/BF02079082
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02079082